Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· HRH.R. 437 (116th)referred
United States · United States Congress · 10 January 2019
Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act This bill prohibits the use of tissue from an induced abortion in research conducted or supported by the National Institutes of Health (NIH). Research with human fetal tissue or alternatives to human fetal tissue (e.g., stem cells) conducted or supported by the NIH must meet requirements currently applied only to research on the transplantation of human fetal tissue for therapeutic purposes, including requirements for the informed consent of the donor and researcher. Research conducted or supported by the NIH may use human fetal tissue only if the tissue was obtained in accordance with state law regulating anatomical gifts. Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals that limitation on executive branch officials. The bill repeals a requirement that the NIH fund certain proposals for research on the transplantation of human fetal tissue for therapeutic purposes.
Bill· SS. 109 (116th)open
United States · United States Congress · 10 January 2019
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2019 This bill modifies provisions relating to federal funding for, and health insurance coverage of, abortions. Specifically, the bill prohibits the use of federal funds for abortions or for health coverage that includes abortions. Such restrictions extend to the use of funds in the budget of the District of Columbia. Additionally, abortions may not be provided in a federal health care facility or by a federal employee. Historically, language has been included in annual appropriations bills for the Department of Health and Human Services (HHS) that prohibits the use of federal funds for abortions—such language is commonly referred to as the Hyde Amendment. Similar language is also frequently included in appropriations bills for other federal agencies and the District of Columbia. The bill makes these restrictions permanent and extends the restrictions to all federal funds (rather than specific agencies). The bill's restrictions regarding the use of federal funds do not apply in cases of rape, incest, or where a physical disorder, injury, or illness endangers a woman's life unless an abortion is performed. The Hyde Amendment provides the same exceptions. The bill also prohibits qualified health plans from including coverage for abortions. Currently, qualified health plans may cover abortion, but the portion of the premium attributable to abortion coverage is not eligible for subsidies.
Bill· SS. 106 (116th)referred
United States · United States Congress · 10 January 2019
Community Health Investment, Modernization, and Excellence Act of 2019 This bill reauthorizes for FY2020-FY2024 and makes appropriations for the Community Health Center Fund, which provides enhanced funding for the community health center program and the National Health Service Corps.
Bill· SS. 105 (116th)referred
United States · United States Congress · 10 January 2019
Title X Abortion Provider Prohibition Act This bill prohibits the Department of Health and Human Services (HHS) from awarding federal family planning grants to entities that provide, or that financially support the provision of, abortions. Specifically, in order to receive such grants, entities must certify that, during the period of the grant, they will not perform abortions or provide funds to entities that perform abortions. Exceptions are made for abortions where (1) the pregnancy is the result of rape or incest; or (2) a physician certifies that the woman suffered from a physical disorder, injury, or illness that would place the woman in danger of death unless an abortion is performed, including a condition caused by or arising from the pregnancy. Hospitals are exempted unless they provide funds to non-hospital entities that perform abortions. HHS must include in an annual report (1) information on grantees who performed abortions under the exceptions, and (2) a list of entities to which grant funds are made available.
Bill· SS. 102 (116th)referred
United States · United States Congress · 10 January 2019
Prescription Drug Price Relief Act of 2019 This bill establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any government-granted exclusivity; (2) issue open, nonexclusive licenses for the drugs; and (3) expedite the review of corresponding applications for generic drugs and biosimilar biological products. HHS must also create a public database with its determinations for each drug. Under the bill, a price is considered excessive if the domestic average manufacturing price exceeds the median price for the drug in Canada, the United Kingdom, Germany, France, and Japan. If a price does not meet this criteria, or if pricing information is unavailable in at least three of the aforementioned countries, the price is still considered excessive if it is higher than reasonable in light of specified factors, including cost, revenue, and the size of the affected patient population. The bill also requires drug manufacturers to report specified financial information for brand-name drugs, including research and advertising expenditures.
Bill· SS. 99 (116th)referred
United States · United States Congress · 10 January 2019
Medicare Drug Price Negotiation Act This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs). Under current law, the Centers for Medicare & Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS to (1) negotiate the prices of covered drugs; and (2) either establish a formulary for covered drugs, or require changes to PDP formularies that take into account CMS negotiations. If the CMS is unable to negotiate an appropriate price for a drug in accordance with certain criteria, the price must be the lowest of three specified options (e.g., the average price in other countries). The CMS must identify drugs that are subject to negotiation, with priority given to certain categories of drugs based on usage and cost. Additionally, drug manufacturers must issue rebates to the CMS for drugs dispensed to eligible low-income individuals. Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
Bill· SS. 97 (116th)referred
United States · United States Congress · 10 January 2019
Affordable and Safe Prescription Drug Importation Act This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
Bill· SS. 95 (116th)referred
United States · United States Congress · 10 January 2019
Veterans Access to Care Act This bill automatically designates medical facilities of the Department of Veterans Affairs (VA) as health professional shortage areas for purposes of the National Health Service Corps Program. Individuals may not participate in both the VA's Health Professionals Education Assistance Program and the National Health Service Corps scholarship or loan repayment programs. The Department of Health and Human Services, in carrying out the National Health Service Corps Program, must consult with the VA regarding health professional shortage areas that are VA medical facilities.
Bill· HRH.R. 373 (116th)referred
United States · United States Congress · 9 January 2019
Fairness for Medical Providers Act of 2019 This bill allows administrative or judicial review of certain decisions by the Centers for Medicare & Medicaid Services (CMS) relating to the Medicare Primary Care Incentive Payment Program. (The program authorized additional payments to certain primary-care practitioners who provided primary-care services on or after January 1, 2011, and before January 1, 2016.) Current law prohibits administrative or judicial review of CMS decisions regarding the eligibility of primary-care practitioners to receive incentive payments under the program. The bill authorizes review of such decisions in cases where the practitioner failed to meet eligibility criteria due to a coding error for provided items and services.
Bill· HRH.R. 366 (116th)referred
United States · United States Congress · 9 January 2019
Insulin Access for All Act of 2019 This bill prohibits cost-sharing (e.g., copayments) under Medicaid and the Medicare prescription drug benefit for insulin and associated medical supplies.
Bill· HRH.R. 383 (116th)referred
United States · United States Congress · 9 January 2019
Continuing Coverage for Preexisting Conditions Act of 2019 This bill establishes severability between provisions relating to the requirement to maintain minimum essential health care coverage (i.e., the individual mandate) and other provisions of the Patient Protection and Affordable Care Act. Specifically, the bill provides that if the individual mandate is found to be illegal or incapable of being enforced, such findings do not affect the validity of other provisions relating to (1) the availability and renewability of coverage, or (2) the prohibitions against discriminatory coverage practices based on preexisting conditions or health status.
Bill· HRH.R. 369 (116th)referred
United States · United States Congress · 9 January 2019
Defund Planned Parenthood Act of 2019 This bill temporarily restricts federal funding for Planned Parenthood Federation of America, Inc. Specifically, the bill prohibits, for a one-year period, the availability of federal funds for any purpose to this entity, or any of its affiliates or clinics, unless they certify that the affiliates and clinics will not perform, and will not provide any funds to any other entity that performs, an abortion during such period. This restriction does not apply in cases of rape or incest or where a physical condition endangers a woman's life unless an abortion is performed. The Department of Health and Human Services and the Department of Agriculture must seek repayment of federal assistance received by Planned Parenthood Federation of America, Inc., or any affiliate or clinic, if it violates the terms of the certification required by this bill. Additional funding for community health centers is provided for the one-year period described above (subject to the same abortion-related restrictions and exceptions).
Bill· SS. 68 (116th)referred
United States · United States Congress · 9 January 2019
Smart Choices Act This bill requires the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission to publish annually a report regarding the effects of Medicaid expansion under the Patient Protection and Affordable Care Act. The report must include funding and coverage information for states participating in Medicaid expansion, as well as information on the potential effects of expansion for states that have not elected to do so.
Bill· SS. 64 (116th)referred
United States · United States Congress · 9 January 2019
Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar. An agreement is exempted if the only consideration granted to the generic manufacturer is (1) the right to market its product prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on any claim that the generic drug or biosimilar infringes a patent. An agreement is also exempt if the agreement's pro-competitive benefits outweigh the anticompetitive effects. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing, or sale of a drug, the manufacturers must certify that the material they have given the FTC concerning the agreement contains the complete agreement and any agreements related to that main agreement, including descriptions of any oral agreements or representations. The bill imposes penalties for violations of this bill, including the forfeiture of the 180-day marketing exclusivity period for a generic drug.
Bill· SS. 62 (116th)referred
United States · United States Congress · 9 January 2019
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 This bill allows the Centers for Medicare & Medicaid Services to (1) negotiate drug prices under the Medicare prescription drug benefit, and (2) institute a price structure for the reimbursement of drugs covered under the benefit.
Bill· SS. 61 (116th)referred
United States · United States Congress · 9 January 2019
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
Law· HRH.R. 266 (116th)enacted
United States · United States Congress · 8 January 2019
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019 This bill provides FY2019 appropriations for the Department of the Interior, the Environmental Protection Agency (EPA), and related agencies. The bill provides appropriations to Interior for the Bureau of Land Management, the U.S. Fish and Wildlife Service, the National Park Service, the U.S. Geological Survey, the Bureau of Ocean Energy Management, the Bureau of Safety and Environmental Enforcement, the Office of Surface Mining Reclamation and Enforcement, and the Bureau of Indian Affairs and Bureau of Indian Education. The bill provides appropriations to Interior for Departmental Offices, including the Office of the Secretary, Insular Affairs, the Office of the Solicitor, the Office of Inspector General, and the Office of the Special Trustee for American Indians. The bill provides appropriations to Interior for Department-Wide Programs, including Wildland Fire Management, the Central Hazardous Materials Fund, the Natural Resources Damage Assessment Fund, the Working Capital Fund, the Office of Natural Resources Revenue, and Payments In Lieu of Taxes (PILT). The bill also provides appropriations to the EPA and the Forest Service. Within the Department of Health and Human Services, the bill provides appropriations for the Indian Health Service, the National Institute of Environmental Health Sciences, and the Agency for Toxic Substances and Disease Registry. The bill provides appropriations for several related agencies, including the Executive Office of the President for the Council on Environmental Quality and the Office of Environmental Quality; the Chemical Safety and Hazard Investigation Board; the Office of Navajo and Hopi Indian Relocation; the Institute of American Indian and Alaska Native Culture and Arts Development; the Smithsonian Institution; the National Gallery of Art; the John F. Kennedy Center for the Performing Arts; the Woodrow Wilson International Center for Scholars; the National Foundation on the Arts and Humanities, including the National Endowment for the Arts and the National Endowment for the Humanities; the Commission of Fine Arts; the Advisory Council on Historic Preservation; the National Capital Planning Commission; the U.S. Holocaust Memorial Museum; the Dwight D. Eisenhower Memorial Commission; the Women's Suffrage Centennial Commission; and the World War I Centennial Commission. Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations Acts.
Bill· HRH.R. 275 (116th)open
United States · United States Congress · 8 January 2019
Medicare Prescription Drug Price Negotiation Act of 2019 This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Law· HRH.R. 299 (116th)enacted
United States · United States Congress · 8 January 2019
Blue Water Navy Vietnam Veterans Act of 2019 This bill addresses certain health benefit and home loan programs for veterans. Specifically, the bill extends the presumption of service-connection for certain diseases associated with herbicide (e.g., Agent Orange) exposure to veterans who served (1) offshore of Vietnam between January 9, 1962, and May 7, 1975, or (2) in or near the Korean Demilitarized Zone between September 1, 1967, and August 31, 1971. Under a presumption of service-connection, specific disabilities or diseases diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded. The bill extends eligibility for health care, vocational training and rehabilitation, and monetary allowance to children with spina bifida who have at least one veteran parent who may have been exposed to an herbicide agent while serving in Thailand between January 9, 1962, and May 7, 1975. Additionally, the bill revises the Department of Veterans Affairs (VA) home loan guaranty program to adjust loan fee rates and eliminate the limit on the amount of a loan for which the VA may provide a guaranty of 25%. Under current law, these loan guarantees are subject to a limit on loan size determined by Freddie Mac. The bill also waives loan fees for active duty Purple Heart recipients. The VA shall permit a VA-approved appraiser to make a housing loan appraisal based solely on information gathered by a person with whom the appraiser has entered into an agreement for such services.
Bill· HRH.R. 293 (116th)referred
United States · United States Congress · 8 January 2019
Youth Vaping Prevention Act of 2019 This bill addresses the use and sale of tobacco products, including by restricting the use of flavors in electronic nicotine delivery systems (e.g., e-cigarettes) and increasing excise taxes on specified tobacco products such as smokeless tobacco, pipe tobacco, and large cigars.
Bill· HRH.R. 326 (116th)referred
United States · United States Congress · 8 January 2019
Victims of Agent Orange Relief Act of 2019 This bill requires the Department of State, the Department of Health and Human Services (HHS), and the Department of Veterans Affairs (VA) to provide assistance to people in Vietnam in relation to Agent Orange exposure. Specifically, the State Department must provide assistance (1) to address the health care needs of certain residents of Vietnam affected by Agent Orange exposure, (2) to institutions in Vietnam that provide health care to such individuals, (3) to improve housing and reduce poverty for specified individuals and their families, and (4) to remediate areas of Vietnam that contain high levels of Agent Orange. HHS must (1) make grants to public health organizations and Vietnamese-American organizations to conduct a broad health assessment of Vietnamese-Americans who may have been exposed to Agent Orange and their descendants; and (2) establish centers in U.S. locations where large populations of Vietnamese-Americans reside to provide assessment, counseling, and treatment for conditions related to Agent Orange exposure. Under the bill, certain benefits will be made available to the children of male veterans who served in Vietnam who are affected by certain birth defects. Currently, these benefits are only available to the children of women Vietnam veterans. The VA shall require any health care provider with whom the VA enters into a contract for the provision of health care to such children to provide the VA access to their medical records for research into the intergenerational effects of Agent Orange exposure.
Bill· HRH.R. 352 (116th)referred
United States · United States Congress · 8 January 2019
Holding Health Insurers Harmless Act This bill exempts health insurers and group health plan sponsors from penalties for offering coverage or plans that fail to comply with the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010. Coverage and plans must continue to comply with (1) the prohibition on excluding preexisting conditions from coverage, and (2) the requirement for coverage of dependent children to be available until the dependent turns 26 years old.
Bill· HRH.R. 345 (116th)referred
United States · United States Congress · 8 January 2019
Strengthening Mosquito Abatement for Safety and Health Act or the SMASH Act This bill reauthorizes for FY2020-FY2024 and revises the Centers for Disease Control and Prevention (CDC) grant program that supports state mosquito control programs. Among other changes, the bill expands the grant program so that grants may be used to address emerging, infectious mosquito-borne diseases and to improve existing control programs. The CDC must also give preference to applicants that have (1) a public health emergency due to a mosquito-borne disease, or (2) a control program that is consistent with existing state preparedness plans. The bill also reauthorizes for FY2020-FY2024 and revises the CDC epidemiology and laboratory capacity grant program, which helps public health agencies improve surveillance and response activities related to infectious diseases.
Bill· HRH.R. 321 (116th)referred
United States · United States Congress · 8 January 2019
Neuromyelitis Optica Consortium Act This bill requires the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis. The consortium must award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.
Bill· HRH.R. 320 (116th)referred
United States · United States Congress · 8 January 2019
Adult Day Center Enhancement Act This bill institutes several requirements for the Administration for Community Living (ACL) relating to certain adult day programs. Specifically, the ACL must conduct a survey of current programs for individuals, including young adults, with neurological diseases or conditions such as multiple sclerosis, Parkinson's disease, or traumatic brain injury. In addition to identifying successful programs, the ACL must also develop best practices for establishing such programs. The ACL must also establish a grant program to fund adult day programs that serve younger people with neurological diseases or conditions.
Bill· HRH.R. 296 (116th)referred
United States · United States Congress · 8 January 2019
Title X Abortion Provider Prohibition Act This bill prohibits the Department of Health and Human Services (HHS) from awarding federal family planning grants to entities that provide, or that financially support the provision of, abortions. Specifically, in order to receive such grants, entities must certify that, during the period of the grant, they will not perform abortions or provide funds to entities that perform abortions. Exceptions are made for abortions where (1) the pregnancy is the result of rape or incest; or (2) a physician certifies that the woman suffered from a physical disorder, injury, or illness that would place the woman in danger of death unless an abortion is performed, including a condition caused by or arising from the pregnancy. Hospitals are exempted unless they provide funds to non-hospital entities that perform abortions. HHS must include in an annual report (1) information on grantees who performed abortions under the exceptions, and (2) a list of entities to which grant funds are made available.
Bill· HRH.R. 280 (116th)referred
United States · United States Congress · 8 January 2019
Concussion Awareness and Education Act of 2019 This bill establishes a series of programs and requirements relating to youth and sports-related concussion research. Among other things, the bill requires the Centers for Disease Control and Prevention to establish a national system to determine the incidence of sports-related concussions among youth. The National Institutes of Health must also conduct or support specified concussion research, such as research regarding predictors and outcome modifiers of youth concussions. The bill also temporarily establishes a Concussion Research Commission. The commission must review supported research and make systemic recommendations regarding youth and sports-related concussions.
Bill· HRH.R. 344 (116th)referred
United States · United States Congress · 8 January 2019
Chiropractic Health Parity for Military Beneficiaries Act This bill directs the Department of Defense to provide chiropractic health care services and benefits through the TRICARE program to uniformed service members who are not on active duty and to uniformed service retirees. (Active duty members of the uniformed services are currently eligible for chiropractic services and benefits through the Chiropractic Health Care Program.)
Bill· HRH.R. 269 (116th)open
United States · United States Congress · 8 January 2019
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs. Among other programs, the bill reauthorizes through FY2023 and revises the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), the Hospital Preparedness Program, the CDC situational-awareness and biosurveillance program, the Emergency System for Advance Registration of Volunteer Health Professionals, the National Disaster Medical System, the Volunteer Medical Reserve Corps, the National Advisory Committee on Children and Disasters, the Strategic National Stockpile, and the Biomedical Advanced Research and Development Authority. In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams. The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.
Bill· HRH.R. 305 (116th)referred
United States · United States Congress · 8 January 2019
Sanctity of Human Life Act This bill declares that (1) the right to life guaranteed by the Constitution is vested in each human and is a person's most fundamental right; (2) each human life begins with fertilization, cloning, or its equivalent, at which time every human has all the legal and constitutional attributes and privileges of personhood; and (3) Congress, each state, the District of Columbia, and each U.S. territory have the authority to protect all human lives.
Bill· SS. 30 (116th)referred
United States · United States Congress · 8 January 2019
Chiropractic Health Parity for Military Beneficiaries Act This bill directs the Department of Defense to provide chiropractic health care services and benefits through the TRICARE program to uniformed service members who are not on active duty and to uniformed service retirees. (Active duty members of the uniformed services are currently eligible for chiropractic services and benefits through the Chiropractic Health Care Program.)
Bill· HRH.R. 260 (116th)referred
United States · United States Congress · 4 January 2019
Medicaid Provisions and TANF Extenders Act of 2019 This bill reauthorizes and revises several Medicaid programs and funding mechanisms, as well as the Temporary Assistance for Needy Families (TANF) program. Specifically, the bill makes appropriations for FY2019 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; reduces the federal medical assistance percentage (i.e., federal matching rate) for states that have not implemented asset-verification programs for determining Medicaid eligibility; reduces funding available to the Medicaid Improvement Fund beginning in FY2021; reauthorizes through FY2020 several grant programs under TANF, such as family assistance grants; and revises state reporting requirements under TANF to include specified employment data, such as employment outcomes for former TANF recipients.
Bill· HRH.R. 249 (116th)referred
United States · United States Congress · 4 January 2019
Federal Accountability in Chemical Testing Act or the FACT Act This bill requires the reports of the Interagency Coordinating Committee on the Validation of Alternative Methods to include a description of the progress on the development and use of alternative methods for toxicological testing by participating federal agencies. Federal agencies that require or recommend toxicological testing must provide the committee with necessary information.
Law· HRH.R. 259 (116th)enacted
United States · United States Congress · 4 January 2019
Medicaid Extenders Act of 2019 This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill makes appropriations for FY2019 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; reduces the federal medical assistance percentage (i.e., federal matching rate) for states that have not implemented asset-verification programs for determining Medicaid eligibility; and reduces funding available to the Medicaid Improvement Fund beginning in FY2021.
Bill· HRH.R. 233 (116th)referred
United States · United States Congress · 3 January 2019
Medicaid Patient Abuse Prevention Act This bill allows state Medicaid fraud control units to investigate complaints of patient abuse or neglect in additional settings. Specifically, the bill allows a unit to review complaints regarding Medicaid patients who are in noninstitutional or other settings. Currently, such units may review complaints regarding patients who are in Medicaid-funded health care facilities or certain board-and-care facilities.
Bill· HRH.R. 220 (116th)referred
United States · United States Congress · 3 January 2019
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019 This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group. The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must: support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders; establish a surveillance system to track the prevalence of such diseases and disorders in humans; establish a surveillance system to track the prevalence of disease-carrying ticks; conduct educational campaigns; and hold a series of research symposiums.
Bill· HRH.R. 207 (116th)referred
United States · United States Congress · 3 January 2019
Stop the Violence Act of 2019 This bill requires the Centers for Disease Control and Prevention (CDC) to establish a grant program that supports violence prevention efforts. Specifically, the CDC must award grants to trauma centers or nonprofit entities for the purpose of conducting or expanding research on the effectiveness of violence prevention efforts in reducing re-injury and re-incarceration that is caused by interpersonal violence. The CDC must also publish best practices for preventing interpersonal violence based on findings from the grant program.
Bill· SS. 22 (116th)referred
United States · United States Congress · 3 January 2019
Medicare Dental Benefit Act of 2019 This bill provides for Medicare coverage of dental and oral health services, including routine diagnostic and preventive services, basic and major dental services, and emergency care; dental prostheses are also covered. Currently, such services are excluded from Medicare coverage.
Bill· SS. 19 (116th)referred
United States · United States Congress · 3 January 2019
Territory Health Insurance Tax Relief Act of 2019 This bill lowers the annual fee on health insurers, specifically for those insurers that collect premiums from residents in U.S. territories. The annual fee for a health insurer is currently calculated based on the insurer's share of total premiums from the preceding calendar year. The bill excludes premiums paid by residents of U.S. territories from a health insurer's net premiums, but still includes the premiums of such residents in the determination of total premiums from the preceding year, thereby lowering the fee for these insurers. Under current law, the fee is suspended for calendar 2019 (i.e., there is no fee based on premiums from calendar 2018).
Bill· SS. 18 (116th)referred
United States · United States Congress · 3 January 2019
State Accountability, Flexibility, and Equity for Hospitals Act of 2019 or the SAFE Hospitals Act of 2019 This bill alters Medicaid requirements relating to payment for inpatient hospital services that are provided by disproportionate share hospitals (DSHs). (DSHs are hospitals that receive additional payment under Medicaid for treating a large share of low-income patients.) Among other changes, the bill requires state Medicaid programs to adopt a payment methodology that meets certain criteria, including by prioritizing payments based on the DSH tier for which the hospital qualifies; tiers are determined based on factors such as the hospital's Medicaid inpatient utilization rate. The bill also incorporates state poverty ratios (i.e., the number of qualifying low-income individuals in a state compared to all states) into the formula for determining state DSH allotments under Medicaid. The bill phases in application of the revised formula over the course of 10 to 15 years.
Bill· SS. 12 (116th)referred
United States · United States Congress · 3 January 2019
Health Savings Act of 201 9 This bill modifies the requirements for health savings accounts (HSAs) to rename high deductible health plans as HSA-qualified health plans; allow spouses who have both attained age 55 to make catch-up contributions to the same HSA; make Medicare Part A (hospital insurance benefits) beneficiaries eligible to participate in an HSA; allow individuals eligible for hospital care or medical services under a program of the Indian Health Service or a tribal organization to participate in an HSA; allow members of a health care sharing ministry to participate in an HSA; allow individuals who receive primary care services in exchange for a fixed periodic fee or payment, or who receive health care benefits from an onsite medical clinic of an employer, to participate in an HSA; include amounts paid for prescription and over-the-counter medicines or drugs as "qualified medical expenses" for which distributions from an HSA or other tax-preferred savings accounts may be used; increase the limits on HSA contributions to match the sum of the annual deductible and out-of-pocket expenses permitted under a high deductible health plan; and allow HSA distributions to be used to purchase health insurance coverage. The bill also: (1) exempts HSAs from creditor claims in bankruptcy, and (2) reauthorizes Medicaid health opportunity accounts. The bill allows a medical care tax deduction for: (1) exercise equipment, physical fitness programs, and membership at a fitness facility; (2) nutritional and dietary supplements; and (3) periodic fees paid to a primary care physician and amounts paid for pre-paid primary care services.
Bill· SS. 11 (116th)referred
United States · United States Congress · 3 January 2019
Strengthening the National Disaster Medical System Act of 2019 This bill makes several changes to the National Disaster Medical System, which is administered by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Among other changes, the bill requires an agency review of the capacity of the system's workforce of intermittent disaster-response personnel to meet the needs of public health emergencies, and temporarily alters the appointment process to address workforce shortages.
Bill· SS. 9 (116th)referred
United States · United States Congress · 3 January 2019
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 This bill exempts traditional large and premium cigars from regulation by the Food and Drug Administration (FDA) and from user fees assessed on tobacco products by the FDA.
Bill· SS. 3 (116th)referred
United States · United States Congress · 3 January 2019
Keeping Health Insurance Affordable Act of 2019 This bill alters and establishes several programs relating to health insurance and prescription drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to establish a public health insurance option through health insurance exchanges. The bill sets forth corresponding implementing provisions, including criteria for payment rates and provider participation. (For example, initial payment rates for providers and services must be set at the same rates as under Medicare; HHS may subsequently alter payment rates in accordance with a specified administrative process.) The bill also expands eligibility for (1) the health insurance premium tax credit, and (2) repayment limitations for excess advance payments of the premium tax credit. Additionally, the bill requires drug manufacturers, as a condition of participation in the Medicare prescription drug benefit, to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for drugs dispensed to certain low-income enrollees. The bill also requires the CMS to (1) negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit, and (2) serve as a prescription drug plan sponsor for a nationwide prescription drug plan under Medicare.
Bill· HRH.R. 96 (116th)open
United States · United States Congress · 3 January 2019
This bill expands eligibility for veterans for dental care provided by the Department of Veterans Affairs (VA). Specifically, the bill makes all veterans who are enrolled in the VA health care system eligible for VA-provided dental services. Currently, only veterans who have a service-connected dental issue or meet other narrow criteria are eligible for certain dental services. The bill phases in eligibility over four years based upon existing eligibility, degree of service-connected disability or other disability, prisoner of war status, award of a Purple Heart, financial need, or VA health care eligibility.
Bill· HRH.R. 135 (116th)open
United States · United States Congress · 3 January 2019
Federal Employee Antidiscrimination Act of 2019 This bill requires each federal agency to establish a model Equal Employment Opportunity Program that is independent of the agency's Human Capital or General Counsel office, and it establishes requirements related to complaints of discrimination and retaliation in the workplace. An agency must publish a notice of any final agency action or Equal Employment Opportunity Commission (EEOC) appellate decision involving a finding of prohibited discrimination or retaliation, and it must report certain data with respect to specified equal opportunity complaints. Each agency must establish a system to track complaints of discrimination and include a notation of any adverse action taken against an employee for discrimination or retaliation in the employee's personnel record. The EEOC must refer to the Office of Special Counsel a matter about which it issues an appellate decision involving a finding of discrimination or retaliation within a federal agency, and the Office of Special Counsel shall accept and review such referral for purposes of seeking disciplinary action. An employee who has authority to take, recommend, or approve any personnel action shall not implement or enforce a nondisclosure policy that prohibits or restricts an employee from disclosing information relating to (1) a violation of any law, rule, or regulation; (2) mismanagement, gross waste of funds, or abuse of authority; (3) a substantial and specific danger to public health or safety; or (4) any other whistle-blower protection.
Bill· HRH.R. 178 (116th)referred
United States · United States Congress · 3 January 2019
Appalachia Opportunity Grants Act of 2019 This bill authorizes the Department of Agriculture to award grants for units of local government in the Appalachian region of the eastern United States to convene groups of public and private entities to collaborate in carrying out regional projects to accomplish positive economic and community impacts in the region. A regional project carried out by a collaborative group must (1) involve at least two municipalities that share a border; and (2) complete a specific activity that has a goal of job creation, expansion of the capacity of post-secondary education, growth of tourism, improving public health, or upgrading regional infrastructure.
Bill· HRH.R. 185 (116th)referred
United States · United States Congress · 3 January 2019
ObamaCare Repeal Act This bill repeals the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, effective as of their enactment. Provisions of law amended by those Acts are restored.
Bill· HRH.R. 83 (116th)referred
United States · United States Congress · 3 January 2019
Responsible Path to Full Obamacare Repeal Act This bill repeals the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, effective at the beginning of FY2020. Provisions of law amended by those Acts are restored.
Bill· HRH.R. 203 (116th)referred
United States · United States Congress · 3 January 2019
Blue Water Navy Vietnam Veterans Act of 2019 This bill addresses certain health benefit and home loan programs for veterans. Specifically, the bill extends the presumption of service-connection for certain diseases associated with herbicide (e.g., Agent Orange) exposure to veterans who served (1) offshore of Vietnam between January 9, 1962, and May 7, 1975, or (2) in or near the Korean Demilitarized Zone between September 1, 1967, and August 31, 1971. Under a presumption of service-connection, specific disabilities or diseases diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded. The bill extends eligibility for health care, vocational training and rehabilitation, and monetary allowance to children with spina bifida who have at least one veteran parent who may have been exposed to an herbicide agent while serving in Thailand between January 9, 1962, and May 7, 1975. Additionally, the bill revises the Department of Veterans Affairs (VA) home loan guaranty program to adjust loan fee rates and eliminate the limit on the amount of a loan for which the VA may provide a guaranty of 25%. Under current law, these loan guarantees are subject to a limit on loan size determined by Freddie Mac. The bill also waives loan fees for active duty Purple Heart recipients. The VA shall permit a VA-approved appraiser to make a housing loan appraisal based solely on information gathered by a person with whom the appraiser has entered into an agreement for such services.
PreviousPage 29 of 30Next